Peter Evan Harwin
CIK 1663607 · last filed 2026-06-11
Peter Evan Harwin is a corporate insider who has filed 23 SEC Form 4 insider transactions across 10 companies since 2020. The most recent filing, for COGT, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$27.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $257.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$257.83M
10
23
$27.41M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Director | — | $33.10 | — | $0 | 6 | 2026-06-11 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | — | $15.70 | — | $0 | 2 | 2026-06-03 |
| ZBIO | Director | 2,209,025 | $19.80 | $43.74M | $24.03M | 2 | 2025-10-09 |
| JBIO | Director | — | $15.34 | — | $0 | 1 | 2025-05-01 |
| ORKA | Director | 798,614 | $69.89 | $55.82M | $0 | 1 | 2024-11-21 |
| VRDN | Director | — | $16.35 | — | $0 | 5 | 2024-06-28 |
| APGE | Director | — | $88.33 | — | $0 | 1 | 2024-06-07 |
| DNTH | Director | 1,928,503 | $82.07 | $158.27M | $3.38M | 3 | 2023-10-03 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 1 | 2020-10-29 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 1 | 2020-08-31 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | COGT | Grant (A) | — | $0 | EDGAR |
| 2026-06-03 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-10-09 | ZBIO | Buy (P) | +1,264,876 | $24.03M | EDGAR |
| 2025-06-23 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | ZBIO | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | COGT | Grant (A) | — | $0 | EDGAR |
| 2025-05-01 | JBIO | Grant (A) | — | $0 | EDGAR |
| 2024-11-21 | ORKA | Exer (M) | +640,000 | $0 | EDGAR |
| 2024-06-28 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | COGT | Grant (A) | — | $0 | EDGAR |